Related Experiment Video
Updated: Oct 30, 2025
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
18.1K
Updates on Clinical Trials in Systemic Lupus Erythematosus
Amir Sharabi1,2
1Rheumatology Institute, Rabin Medical Center, Petach-Tikva, Israel. isharabiamir@gmail.com.
Current Rheumatology Reports
|July 2, 2021
Summary
New clinical trials are exploring novel treatments for systemic lupus erythematosus (SLE). Research focuses on targeting B cells, interferons, and employing small molecule inhibitors for SLE therapeutic development.
Area of Science:
- Immunology
- Rheumatology
- Pharmacology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease.
- Investigating novel therapeutic compounds for SLE requires diverse approaches.
Purpose of the Study:
- To review recent clinical trials investigating compounds for SLE treatment.
- To summarize emerging therapeutic strategies for managing SLE.
Main Methods:
- Analysis of recent clinical trial data for SLE therapeutics.
- Focus on targeted therapies including B-cell and interferon pathways.
- Evaluation of small molecule inhibitors (JAK, Tyk, Btk) and immunomodulatory agents (IL-2, CD40 ligand inhibition).
Main Results:
- Recent trials heavily focus on B-cell and type I interferon targets.
- Small molecule inhibitors and T-cell immunoregulation are under investigation.
- Bispecific antibodies and combination treatments are emerging strategies.
Conclusions:
- Clinical trials are actively exploring new SLE treatments.
- Anticipation of novel therapeutic compounds for SLE management.
- Targeted and combination therapies show promise for SLE.
Related Concept Videos
01:11Clinical Trials: Overview
4.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.0K
01:16Clinical Trials
9.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.9K
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
153
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
153
01:26Nephrotic Syndrome II : Assessment and Medical Management
47
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
47
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
151
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
151
01:24Nephrotic Syndrome I : Introduction
223
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
223